Aspirin may decrease the risk for developing high-grade prostate cancer
the ONA take:
According to new findings presented at the 13th Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research in New Orleans, Louisiana, the use of aspirin and other other non-steroidal anti-inflammatory drugs (NSAIDs) were associated with a decreased risk for developing an aggressive form of prostate cancer in patients who had a negative biopsy despite an increased prostate specific antigen (PSA).
The researchers used patients from the REDUCE trial, which studied if dutasteride, a 5-alpha reductase inhibitor, lowers the risk for developing prostate cancer.
Of the 6,390 participants with a PSA between 2.5 ng/mL and 10 ng/mL and a negative biopsy prior to the study, 50% were aspirin/NSAID nonusers, 21% were aspirin users, 18% were NSAID users, and 11% were users of both drugs. They found that aspirin and/or NSAID use decreased the risk for developing prostate cancer by 14%, and after adjusting for confounding factors, 13%.
Furthermore, they found that aspirin and/or NSAID use lowered the risk of high-grade disease by 17%. No link was observed with low-grade prostate cancer. Results were similar among patients from different continents.
Aspirin and other other NSAIDs were associated with a decreased risk for aggressive prostate cancer.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|